Catalyst Wire Dossier Catalyst Wire Dossier

ADALIMUMAB-ADBM

adalimumab · QUALLENT PHARMACEUTICALS HEALTH LLC
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for ADALIMUMAB-ADBM, covering 2017-08-25 to 2025-10-16. Get the full timeline:

Most recent: FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

See pricing